Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
The COVID-19 pandemic has raised considerable concerns that patients with inflammatory
bowel disease (IBD), particularly those treated with immunosuppressive therapies, may …
bowel disease (IBD), particularly those treated with immunosuppressive therapies, may …
[HTML][HTML] A comprehensive high cost drugs dataset from the NHS in England-An OpenSAFELY-TPP Short Data Report
Background: At the outset of the COVID-19 pandemic, there was no routine comprehensive
hospital medicines data from the UK available to researchers. These records can be …
hospital medicines data from the UK available to researchers. These records can be …